PCLO.V - PharmaCielo Ltd.

TSXV - TSXV Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 581.6M
Enterprise Value 372.1M
Trailing P/E N/A
Forward P/E 12.56
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)62.71
Price/Book (mrq)1.83
Enterprise Value/Revenue 355.41
Enterprise Value/EBITDA 6-2.21

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-87.10%
S&P500 52-Week Change 35.66%
52 Week High 36.1000
52 Week Low 30.5000
50-Day Moving Average 30.7782
200-Day Moving Average 31.4986

Share Statistics

Avg Vol (3 month) 3154.24k
Avg Vol (10 day) 3142.38k
Shares Outstanding 5118.27M
Float 93.24M
% Held by Insiders 116.39%
% Held by Institutions 13.35%
Shares Short (Jun. 29, 2020) 43.6M
Short Ratio (Jun. 29, 2020) 418.89
Short % of Float (Jun. 29, 2020) 4N/A
Short % of Shares Outstanding (Jun. 29, 2020) 43.26%
Shares Short (prior month May 28, 2020) 41.22M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:11
Last Split Date 3Jan. 17, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Mar. 30, 2020


Profit Margin 0.00%
Operating Margin (ttm)-2,572.65%

Management Effectiveness

Return on Assets (ttm)-38.23%
Return on Equity (ttm)-67.61%

Income Statement

Revenue (ttm)1.3M
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)643.48k
EBITDA -32.56M
Net Income Avi to Common (ttm)-33.25M
Diluted EPS (ttm)-0.3410
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.49M
Total Cash Per Share (mrq)0.06
Total Debt (mrq)1.5M
Total Debt/Equity (mrq)4.01
Current Ratio (mrq)2.59
Book Value Per Share (mrq)0.38

Cash Flow Statement

Operating Cash Flow (ttm)-24.58M
Levered Free Cash Flow (ttm)-21.66M